Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer
PHASE3
The purpose of this study is to assess the efficacy of FOLFOX + panitumumab...
Status
Active Not Recruiting
Location
Spanish Cooperative Group for the Treatment of Digestive Tumors
A Randomized, Open-Label, Controlled, Multicenter Phase III Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus Standard Therapy as First-Line Treatment for Advanced Colorectal Cancer
PHASE3
This study adopts a randomized, open-label, positive-controlled, multicente...